The use of oral opioids to control children's pain in the post-codeine era

Michael J Rieder1, Geert 't Jong1

  • 1Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee, Ottawa, Ontario.

Insights

Oral opioids are used for moderate to severe pain in children, but codeine use has declined. Oral morphine shows the most safety and efficacy, but more research on other opioids and non-opioid options is needed.

Area of Science:

  • Pediatric Pain Management
  • Pharmacology
  • Evidence-Based Medicine

Background:

  • Pain is a prevalent issue in pediatric care, requiring effective pharmacologic and nonpharmacologic management strategies.
  • Oral opioids have been widely used for moderate to severe pediatric pain, with codeine historically being a common choice.
  • Declining availability and safety concerns associated with codeine have necessitated the exploration of alternative analgesics for children.

Purpose of the Study:

  • To review the current evidence on the safety and efficacy of various oral opioids used for moderate to severe pain management in children.
  • To identify gaps in knowledge regarding the use of alternative opioids such as oxycodone, hydromorphone, and tramadol in pediatric populations.
  • To highlight oral morphine as an alternative with substantial evidence for pediatric use and to emphasize the need for further research.

Main Methods:

  • Literature review and synthesis of existing studies on oral opioid analgesics in pediatric pain management.
  • Analysis of pharmacokinetic and pharmacodynamic data for commonly used opioids in children.
  • Evaluation of safety and efficacy data from clinical trials and observational studies.

Main Results:

  • Codeine use in children has significantly decreased due to safety concerns.
  • Limited data exist on the efficacy and safety of oxycodone, hydromorphone, and tramadol in pediatric patients.
  • Oral morphine demonstrates the most robust evidence for safety and efficacy as a codeine alternative in children.

Conclusions:

  • Oral morphine is a viable alternative to codeine for moderate to severe pain in children, supported by the most extensive evidence.
  • Further research is crucial to establish the safety and efficacy profiles of other opioid analgesics and non-opioid therapies for pediatric pain.
  • Evidence-based guidelines are needed to optimize analgesic therapy for children experiencing moderate to severe pain.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
637
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
566
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.1K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
994
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
457
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.0K